| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13378daf1ea3e93deba77c21f881e972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ead1db9e234031c7644bb7e290fae8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_528d937a1f59421846176509ee2ad277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ecb3865ce3c08a0d7dacd250527c4e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-00 |
| filingDate |
2004-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_200b28634baa264b9e342b589da6cbdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cc3cefb0e2cc83d3193f64443616ffd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee7e98e5a12bfafdc9de59efc1529150 |
| publicationDate |
2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004103990-A1 |
| titleOfInvention |
Process for producing optically active n-monoalkyl-3hydroxy-3-arylpropylamine compound and intermediate |
| abstract |
A process for producing an optically active N-monoalkyl3-oxo-3-arylpropylamine compound represented by the formula (3): (wherein symbol * indicates an asymmetric carbon atom and R1 represents optionally substituted C1-5 alkyl), characterized by asymmetrically reducing a (Z)-protected-N-monoalkyl-3-oxo-3-arylpropenylamine compound represented by the formula (1): (wherein Ar represents optionally substituted aryl, etc.; R1 is the same as defined above; and R2 represents an amino-protecting group) with an asymmetric catalyst to give an optically active compound represented by the formula (2): (wherein symbol * is the same as defined above) and successively eliminating the protective group. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722906-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010235604-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8183392-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5361187-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2011118625-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013256501-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007020797-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102822161-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006104249-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008004191-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011118625-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8981122-B2 |
| priorityDate |
2003-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |